SCHEMBL6547106

SCHEMBL6547106

COc1ccc(-c2nc(NC(=O)c3ccccc3)sc2-c2cc[n+]([O-])cc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.73
▸ KMT2A Q03164 4/20 0.73
▸ MEN1 O00255 3/20 0.73
▸ USP2 O75604 1/20 0.73
▸ CYP2C9 P11712 1/20 0.73
▸ CYP2C19 P33261 1/20 0.73
▸ SMN1; SMN2 Q16637 3/20 0.65
▸ LMNA P02545 2/20 0.65
▸ RECQL P46063 1/20 0.65
▸ L3MBTL1 Q9Y468 1/20 0.65
▸ THRB P10828 1/20 0.65
▸ ALDH1A1 P00352 3/20 0.64
▸ ADORA3 P0DMS8 9/20 0.62
▸ ADORA1 P30542 7/20 0.62
▸ KDM4E B2RXH2 1/20 0.60
▸ GAA P10253 1/20 0.60
▸ ADORA2A P29274 2/20 0.55
▸ PTGS2 P35354 1/20 0.54
▸ NPC1 O15118 1/20 0.53
▸ RAB9A P51151 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL206504 0.91 MAPT (0.82) MAPTKMT2AMEN1USP2CYP2C9
SCHEMBL6545848 0.89 MAPT (0.59) MAPTKMT2AMEN1USP2CYP2C9
SCHEMBL6546069 0.88 KMT2A (0.56) MAPTKMT2AMEN1USP2CYP2C9
SCHEMBL235277 0.87 ADORA1 (0.78) MAPTKMT2AMEN1USP2CYP2C9
SCHEMBL6545476 0.86 MAPT (0.74) MAPTKMT2AMEN1USP2CYP2C9
SCHEMBL6546857 0.86 MAPT (0.81) MAPTKMT2AMEN1USP2CYP2C9
SCHEMBL6546561 0.85 KMT2A (0.54) MAPTKMT2AMEN1USP2CYP2C9
SCHEMBL6546216 0.84 ADORA3 (0.62) MAPTKMT2AMEN1USP2CYP2C9
SCHEMBL6547114 0.84 MAPT (0.63) MAPTKMT2AMEN1USP2CYP2C9
SCHEMBL6545809 0.83 MAPT (0.62) MAPTKMT2AMEN1USP2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1027050-B1 1,3-THIAZOLES AS ADENOSINE A3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ALLERGY, ASTHMA AND DIABETES TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-01-14 — — EP disclosed
US-6620825-B1 1,3-Azole compound substituted by pyridyl; administering as antiasthmatic, antiinflammatory or antiallergen agents TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-16 — — US disclosed
US-6436966-B1 Adenosine A3 receptor antagonists TAKEDA CHEMICAL IND., LTD. (JP) 2002-08-20 — — US disclosed
Send feedback